China Pharma Holdings, Inc. financial data

Symbol
CPHI on NYSE
Industry
Pharmaceutical Preparations
Location
2 Nd Floor, No. 17, Jinpan Road, Haikou, Hainan Province, China
State of incorporation
DE
Fiscal year end
December 31
Former names
TS ELECTRONICS INC (to 5/4/2006), SOFTSTONE INC (to 8/18/2003), SOFTSTONE INC /DE/ (to 1/27/2003), KILKENNY ACQUISITION CORP (to 3/30/2001)
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 64.4 % +8.11%
Quick Ratio 41.8 % +37.2%
Debt-to-equity 187 % -45.3%
Return On Equity -63.2 % -15.9%
Return On Assets -19 % +12.9%
Operating Margin -39.3 % +10.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 32.6M shares +120%
Common Stock, Shares, Outstanding 32.6M shares +207%
Entity Public Float 4.29M USD +10.1%
Common Stock, Value, Issued 32.6K USD +207%
Weighted Average Number of Shares Outstanding, Basic 17.3M shares +555%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.1M USD -39%
Cost of Revenue 1.62M USD -20.5%
Research and Development Expense 87.6K USD +91.4%
General and Administrative Expense 345K USD +40.1%
Operating Income (Loss) -1.09M USD -52.1%
Nonoperating Income (Expense) -32.7K USD +49%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.12M USD -43.8%
Net Income (Loss) Attributable to Parent -4.74M USD -53.8%
Earnings Per Share, Basic -0.06 USD/shares +79.3%
Earnings Per Share, Diluted -0.06 USD/shares +79.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 600K USD -57.9%
Accounts Receivable, after Allowance for Credit Loss, Current 232K USD -54%
Inventory, Net 2.27M USD -39.3%
Assets, Current 3.27M USD -45.5%
Property, Plant and Equipment, Net 4.88M USD -31.2%
Operating Lease, Right-of-Use Asset 38.3K USD -67.2%
Intangible Assets, Net (Excluding Goodwill) 6.7M USD +106%
Assets 14.9M USD -9.6%
Accrued Liabilities, Current 247K USD -17.3%
Contract with Customer, Liability, Current 162K USD +79.2%
Liabilities, Current 5.02M USD -26.4%
Deferred Income Tax Liabilities, Net 731K USD -1.47%
Operating Lease, Liability, Noncurrent 39.9K USD
Liabilities 7.14M USD -20.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 11.3M USD -1.16%
Retained Earnings (Accumulated Deficit) -44M USD -12.1%
Stockholders' Equity Attributable to Parent 7.75M USD +3.93%
Liabilities and Equity 14.9M USD -9.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.47M USD -66.9%
Net Cash Provided by (Used in) Financing Activities 518K USD
Net Cash Provided by (Used in) Investing Activities 56K USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 32.6M shares +207%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -863K USD +24.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 627K USD -56%
Interest Paid, Excluding Capitalized Interest, Operating Activities 22.9K USD -89.5%
Deferred Tax Assets, Valuation Allowance 21.7M USD +17.8%
Deferred Tax Assets, Gross 21.7M USD +17.8%
Operating Lease, Liability 39.3K USD -66.6%
Depreciation 592K USD -6.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -980K USD -38.8%
Lessee, Operating Lease, Liability, to be Paid 39.7K USD -67.2%
Property, Plant and Equipment, Gross 37M USD -1.37%
Operating Lease, Liability, Current 39.3K USD -49.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 40.3K USD -1.67%
Lessee, Operating Lease, Liability, to be Paid, Year One 39.7K USD -50.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure -21.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 409 USD -87.7%
Deferred Tax Assets, Operating Loss Carryforwards 2.08M USD +12.4%
Preferred Stock, Shares Authorized 5M shares 0%
Operating Lease, Payments 21.1K USD +4.56%
Additional Paid in Capital 40.6M USD +15.1%
Amortization of Intangible Assets 105K USD +99.7%
Depreciation, Depletion and Amortization 680K USD -4.72%
Deferred Tax Assets, Net of Valuation Allowance 22.6M USD +5.01%
Interest Expense 6.84K USD -1.43%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%